Additionally, our study reveals that NBTL concurrently inhibits both VEGFR1 and VEGFR2, a finding that deviates from the conventional focus on VEGFR2 as the primary pro-angiogenic factor in RA. The gene discussed is FLT1; the disease is rheumatoid arthritis.